PIŚMIENNICTWO
1. Acierno MJ, Brown S, Coleman AE, et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018;32(6):1803-1822. doi:10.1111/jvim.15331
2. Bodey AR, Michell AR. Epidemiological study of blood pressure in domestic dogs. J Small Anim Pract. 1996;37(3):116‐125. doi:10.1111/j.1748-5827.1996.tb02358.x
3. Bright JM, Dentino M. Indirect arterial blood pressure measurement in nonsedated Irishwolfhounds: reference values for the breed. J Am Anim Hosp Assoc. 2002;38(6):521‐526. doi:10.5326/0380521
4. Kallet AJ, Cowgill LD, Kass PH. Comparison of blood pressure measurements obtained in dogs by use of indirect oscillometry in a veterinary clinic versus at home. J Am Vet Med Assoc. 1997;210(5):651‐654.
5. Stepien RL, Rapoport GS. Clinical comparison of three methods to measure blood pressure in nonsedated dogs. J Am Vet Med Assoc. 1999;215(11):1623-1628.
6. Belew AM, Barlett T, Brown SA. Evaluation of the white‐coat effect in cats. J Vet In-tern Med. 1999;13(2):134‐142. doi:10.1892/0891-6640(1999)013<0134:eotwce>2.3.co;2
7. Brown SA, Langford K, Tarver S. Effects of certain vasoactive agents on the long-term pattern of blood pressure, heartrate, and motor activity in cats. Am J Vet Res. 1997;58(6):647-652.
8. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2007;21:542-558. doi:10.1111/j.1939-1676.2007.tb03005.x
9. Maggio F, De Francesco TC, Atkins CE, Pizzirani S, Gilger BC, Davidson MG. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985‐1998). J Am Vet Med Assoc. 2000;217(5):695‐702. doi:10.2460/javma.2000.217.695
10. Elliott J, Barber PJ, Syme HM, Rawlings JM, Markwell PJ. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract. 2001;42(3):122‐129. doi:10.1111/j.1748-5827.2001.tb02008.x
11. Chetboul V, Lefebvre HP, Pinhas C, Clerc B, Boussouf M, Pouchelon JL. Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. J Vet Intern Med. 2003;17(1):89‐95. doi:10.1892/0891-6640(2003)017<0089:sfhcae>2.3.co;2
12. Carter JM, Irving AC, Bridges JP, Jones BR. The prevalence of ocular lesions associated with hypertension in a population of geriatric cats in Auckland, New Zealand. NZ Vet J. 2014;62(1):21‐29. doi:10.1080/00480169.2013.823827
13. Littman MP, Robertson JL, Bovee KC. Spontaneous systemic hypertension in dogs: five cases (1981‐1983). J Am Vet Med Assoc. 1988;193(4):486‐494.
14. Bovee KC, Littman MP, Crabtree BJ, Aguirre G. Essential hypertension in a dog. J Am Vet Med Assoc. 1989;195(1):81‐86.
15. Crispin SM, Mould JR. Systemic hypertensive disease and the feline fundus. Vet Ophthalmol. 2001;4(2):131‐140. doi:10.1046/j.1463-5224.2001.00190.x
16. Leblanc NL, Stepien RL, Bentley E. Ocular lesions associated with systemic hypertension in dogs: 65 cases (2005‐2007). J Am Vet Med Assoc. 2011;238(7):915‐921. doi:10.2460/javma.238.7.915
17. Morgan RV. Systemic hypertension in four cats: ocular and medical findings. J Am Anim Hosp Assoc. 1986;22(5):615‐621.
18. Jacob F, Polzin DJ, Osborne CA, et al. Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure. J Am Vet Med Assoc. 2003;222(3):322‐329. doi:10.2460/javma.2003.222.322
19. Littman MP. Spontaneous systemic hypertension in 24 cats. J Vet Intern Med. 1994;8(2):79‐86. doi:10.1111/j.1939-1676.1994.tb03202.x
20. Kyles AE, Gregory CR, Wooldridge JD, et al. Management of hypertension controls postoperative neurologic disorders after renal transplantation in cats. Vet Surg. 1999;28(6):436‐441. doi:10.1111/j.1532-950x.1999.00436.x
21. Mathur S, Syme H, Brown CA, et al. Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. Am J Vet Res. 2002;63(6):833‐839. doi:10.2460/ajvr.2002.63.833
22. Lowrie M, De Risio L, Dennis R, Llabres-Diaz F, Garosi L. Concurrent medical conditions and long‐term outcome in dogs with nontraumatic intracranial hemorrhage. Vet Radiol Ultrasound. 2012;53(4):381‐388. doi:10.1111/j.1740-8261.2012.01934.x
23. Littman MP, Drobatz KJ. Hypertensive and hypotensive disorders. In: Ettinger SJ, ed. Textbook of Veterinary Internal Medicine. W. B. Saunders; 1995:93‐100.
24. Lesser M, Fox PR, Bond BR. Assessment of hypertension in 40 cats with left ventricular hypertrophy by Doppler‐shift sphygmomanometry. J Small Anim Pract. 1992;33(2):55‐58. doi:10.1111/j.1748-5827.1992.tb01072.x
25. Bissett SA, Drobatz KJ, McKnight A, Degernes LA. Prevalence, clinical features, and causes of epistaxis in dogs: 176 cases (1996–2001). J Am Vet Med Assoc. 2007;231(12):1843‐1850. doi:10.2460/javma.231.12.1843
26. Mylonakis ME, Saridomichelakis MN, Lazaridis V, Leontides LS, Kostoulas P, Koutinas AF. A retrospective study of 61 cases of spontaneous canine epistaxis (1998 to 2001). J Small Anim Pract. 2008;49(4):191‐196. doi:10.1111/j.1748-5827.2007.00441.x
27. Strasser JL, Hawkins EC. Clinical features of epistaxis in dogs: a retrospective study of 35 cases (1999‐2002). J Am Anim Hosp Assoc. 2005;41(3):179‐184. doi:10.5326/0410179
28. Syme HM, Markwell PJ, Pfeiffer D, Elliott J. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med. 2006;20(3):528‐535. doi:10.1892/0891-6640(2006)20[528:socwno]2.0.co;2
29. King JN, Gunn‐Moore DA, Tasker S, Gleadhill A, Strehlau G; Benazepril in Renal Insufficiency in Cats Study Group. Tolerability and efficacy of benazepril in cats with chronic kidney disease. J Vet Intern Med. 2006;20(5):1054‐1064. doi:10.1892/0891-6640(2006)20[1054:taeobi]2.0.co;2
30. Jepson RE, Brodbelt D, Vallance C, Syme HM, Elliott J. Evaluation of predictors of the development of azotemia in cats. J Vet Intern Med. 2009;23(4):806‐813. doi:10.1111/j.1939-1676.2009.0339.x
31. Chakrabarti S, Syme HM, Elliott J. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. J Vet Intern Med. 2012;26(2):275-281. doi:10.1111/j.1939-1676.2011.00874.x
32. Wehner A, Hartmann K, Hirschberger J. Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non‐renal diseases. Vet Rec. 2008;162(5):141‐147. doi:10.1136/vr.162.5.141
33. Finco DR. Association of systemic hypertension with renal injury in dogs with induced renal failure. J Vet Intern Med. 2004;18(3):289‐294. doi:10.1892/0891-6640(2004)18<289:aoshwr>2.0.co;2
34. Ortega TM, Feldman EC, Nelson RW, Willits N, Cowgill LD. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc. 1996;209(10):1724‐1729.
35. Francey T, Cowgill LD. Hypertension in dogs with severe acute renal failure. J Vet Intern Med. 2004;18:418(A).
36. Anderson LJ, Fisher EW. The blood pressure in canine interstitial nephritis. Res Vet Sci. 1968;9(4):304-313.
37. Kobayashi DL, Peterson ME, Graves TK, Lesser M, Nichols CE. Hypertension in cats with chronic renal failure or hyperthyroidism. J Vet Intern Med. 1990;4(2):58‐62. doi:10.1111/j.1939-1676.1990.tb03104.x
38. Brown SA, Brown CA, Jacobs G, Stiles J, Hendi RS, Wilson S. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am J Vet Res. 2001;62(3):375-383. doi:10.2460/ajvr.2001.62.375
39. Schellenberg S, Mettler M, Gentilini F, Portmann R, Glaus TM, Reusch CE. The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs. J Vet Intern Med. 2008;22(2):273-281. doi:10.1111/j.1939-1676.2007.0039.x
40. Ueno Y, Mohara O, Brosnihan KB, Ferrario CM. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension. Hypertension. 1988;11(2Pt2):I172-I177. doi:10.1161/01.hyp.11.2_pt_2.i172
41. Ash RA, Harvey AM, Tasker S. Primary hyperaldosteronism in the cat: a series of 13 cases. J Feline Med Surg. 2005;7(3):173-182. doi:10.1016/j.jfms.2004.08.007
42. Wimpole JA, Adagra CFM, Billson MF, Pillai DN, Foster DJ. Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma. J Feline Med Surg. 2010;12(6):435-440. doi:10.1016/j.jfms.2009.10.010
43. Struble AL, Feldman EC, Nelson RW, Kass PH. Systemic hypertension and proteinuria in dogs with diabetes mellitus. J Am Vet Med Assoc. 1998;213(6):822-825.
44. Cowgill LD, James KM, Levy JK, et al. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc. 1998;212(4):521‐528.
45. Gouni V, Tissier R, Misbach C, et al. Influence of the observer’s level of experience on systolic and diastolic arterial blood pressure measurements using Doppler ultra-sonography in healthy conscious cats. J Feline Med Surg. 2015;17(2):94‐100. doi:10.1177/1098612X14532087
46. Marino CL, Cober RE, Iazbik MC, Couto CG. White‐coat effect on systemic blood pressure in retired racing Greyhounds. J Vet Intern Med. 2011;25(4):861‐865. doi:10.1111/j.1939-1676.2011.00735.x
47. Surman S, Couto CG, Dibartola SP, Chew DJ. Arterial blood pressure, proteinuria, and renal histopathology in clinically healthy retired racing greyhounds. J Vet Intern Med. 2012;26(6):1320-1329. doi:10.1111/j.1939-1676.2012.01008.x
48. Rondeau DA, Mackalonis ME, Hess RS. Effect of body position on indirect measurement of systolic arterial blood pressure in dogs. J Am Vet Med Assoc. 2013;242(11):1523‐1527. doi:10.2460/javma.242.11.1523
49. Scansen BA, Vitt J, Chew DJ, Schober KE, Bonagura JD. Comparison of forelimb and hindlimb systolic blood pressures and proteinuria in healthy Shetland sheep-dogs. J Vet Intern Med. 2014;28(2):277‐283. doi:10.1111/jvim.12289
50. Remillard RL, Ross JN, Eddy JB. Variance of indirect blood pressure measurements and prevalence of hypertension in clinically normal dogs. Am J Vet Res. 1991;52(4):561‐565.
51. Meurs KM, Miller MW, Slater MR, Glaze K. Arterial blood pressure measurement in a population of healthy geriatric dogs. J Am Anim Hosp Assoc. 2000;36(6):497‐500. doi:10.5326/15473317-36-6-497
52. Schneider HP, Truex RC, Knowles JO. Comparative observations of the hearts of mongrel and greyhound dogs. Anat Rec. 1964;149:173‐179. doi:10.1002/ar.1091490202
53. Bijsmans ES, Jepson RE, Chang YM, Syme HM, Elliott J. Changes in systolic blood pressure overtime in healthy cats and cats with chronic kidney disease. J Vet Intern Med. 2015;29(3):855‐861. doi:10.1111/jvim.12600
54. Sent U, Gössl R, Elliott J, Syme HM, Zimmering T. Comparison of efficacy of long-term oral treatment with telmisartan and benazepril in cats with chronic kidney disease. J Vet Intern Med. 2015;29(6):1479-1487. doi:10.1111/jvim.13639
55. Jenkins TL, Coleman AE, Schmiedt CW, Brown SA. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats. Am J Vet Res. 2015;76(9):807‐813. doi:10.2460/ajvr.76.9.807
56. Glaus AM, Elliott J, Albrecht B. Efficacy of telmisartan in hypertensive cats: results of alarge European clinical trial. Presented at: 27th ECVIM‐CA Congress; September 14-16, 2017; St. Julian’s, Malta. https://www.vin.com/apputil/content/defaul-tadv1.aspx?pId=19132&catId=103558&id=8172783&ind=336&objTypeID=17
57. Grauer GF, Greco DS, Getzy DM, et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med. 2000;14(5):526‐533. doi:10.1892/0891-6640(2000)014<0526:eoevpa>2.3.co;2
58. Brown S. Introduction from the International Renal Interest Society. J Vet Intern Med. 2013;27(suppl1):S1. doi:10.1111/jvim.12229
59. Henik RA, Stepien RL, Wenholz LJ, Dolson MK. Efficacy of atenolol as a single anti-hypertensive agent in hyperthyroid cats. J Feline Med Surg. 2008;10(6):577‐582. doi:10.1016/j.jfms.2007.11.008
